| DIRECT COMPETITOR COMPARISON | |
| CRXX | AMGN | Pvt1 | Pvt2 | Industry | | Market Cap: | 37.11M | 57.55B | N/A | N/A | 96.35M | | Employees: | 73 | 16,700 | N/A | 11,1741 | 68 | | Qtrly Rev Growth (yoy): | -8.10% | -1.60% | N/A | N/A | 19.70% | | Revenue (ttm): | 12.15M | 14.58B | N/A | 13.42B1 | 13.84M | | Gross Margin (ttm): | 100.00% | 84.99% | N/A | N/A | 64.07% | | EBITDA (ttm): | -25.51M | 6.71B | N/A | N/A | -12.25M | | Oper Margins (ttm): | -253.95% | 38.71% | N/A | N/A | -149.46% | | Net Income (ttm): | -38.06M | 4.74B | N/A | N/A | N/A | | EPS (ttm): | -0.718 | 4.585 | N/A | N/A | -0.33 | | P/E (ttm): | N/A | 12.40 | N/A | N/A | 17.95 | | PEG (5 yr expected): | N/A | 1.3 | N/A | N/A | 1.27 | | P/S (ttm): | 3.05 | 3.95 | N/A | N/A | 9.75 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.86 | 0.00% | 57.55B | 12.40 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 48.87 | 0.00% | 14.13B | 16.36 | | Genzyme Corp. | GENZ | 49.98 | 0.00% | 13.26B | 28.49 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.96 | 0.00% | 42.26B | 18.16 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 51.62 | 0.00% | 9.21B | 1053.47 | | Teva Pharmaceutical Industries Limited | TEVA | 53.49 | 0.00% | 47.12B | 48.94 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 38.65 | 0.00% | 4.10B | 19.92 | | King Pharmaceuticals Inc. | KG | 11.84 | 0.00% | 2.94B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.77 | 0.00% | 5.74B | 115.15 | | Pfizer Inc. | PFE | 18.40 | 0.00% | 148.48B | 15.28 | | Johnson & Johnson | JNJ | 64.96 | 0.00% | 179.23B | 14.19 | | GlaxoSmithKline plc | GSK | 42.91 | 0.00% | 108.78B | 13.80 | | Sanofi-Aventis | SNY | 38.76 | 0.00% | 101.21B | N/A | | Novartis AG | NVS | 54.21 | 0.00% | 123.12B | 16.23 |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | RHHBY.PK | 41.00 | 0.00% | N/A | N/A | | AstraZeneca plc | AZN | 45.78 | 0.00% | 66.38B | 9.19 | | Abbott Laboratories | ABT | 53.78 | 0.00% | 83.18B | 14.57 | | Bristol-Myers Squibb Co. | BMY | 25.96 | 0.00% | 51.43B | 13.43 |
|
| NEWS ON DIRECT COMPETITORS | |
|
|
|